POMDOCTOR Ltd(POM)— Stock Profile, AI Score & Financials
Consumer Discretionary · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .
POMDOCTOR Ltd (POM) stock profile, AI quality score, and SEC EDGAR financial data, a Consumer Discretionary sector company. POM is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least 50 unique 13-f institutional holders to ensure peer comparisons are meaningful. only 10 institutional filers currently hold this stock. Based on the latest XBRL financial filings (FY 2025), POMDOCTOR Ltd reports quarterly revenue of $57.2M, net income of $-18.7M, free cash flow of $-21.4M. Top institutional holders of POM by reported 13-F value include CITADEL ADVISORS, UBS Group AG, Caitong International Asset Management , Ltd, based on the most recent SEC filings. POM trades on the Nasdaq exchange and files with the SEC under CIK 1877971. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate POM daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for POMDOCTOR Ltd directly from SEC EDGAR.
Revenue
$57.2M
Net Income
$-18.7M
Free Cash Flow
$-21.4M
POM key financials by period
POMDOCTOR Ltd reported revenue, net income and margins by fiscal period, from SEC filings.
Period
Form
Revenue
Net income
Operating margin
FY 2025
20-F
$399.9M
—
-29.7%
FY 2024
20-F
$342.6M
—
-7.5%
FY 2023
20-F
$304.9M
—
-7.3%
Institutions holding POM
Institutional investors reporting a position in POMDOCTOR Ltd on SEC Form 13F.
Quality rankings require at least 50 unique 13-F institutional holders to ensure peer comparisons are meaningful. Only 10 institutional filers currently hold this stock.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
Price Chart
Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
